top of page

Search Results

Search this site

465 results found with an empty search

  • COVID-19 Pandemic v Epidemics since 2000

    Kudos to harry29ford! He has produced a fantastic piece of visualisation to produce a great illustration of how COVID-19 deaths have evolved over time (from the date of the first death) compared to epidemics of the 21st century to date. An epidemic occurs when there is a rapid spread of a disease to a larger number of people in a given population within a short period of time. A pandemic is an epidemic that has spread across a continent or globally. This video shows the difference very clearly!

  • COVID-19: Unprecedented event?

    COVID-19 – An event without precedent? SARS-CoV-2 is a novel (new) strain of Coronavirus so the disease it causes – COVID-19 – is something everyone is having to learn about as we go along. Deadly Coronaviruses are not new There are many types of Coronavirus and whilst most cause only mild illnesses, at least two other human coronaviruses are known to cause severe symptoms: (1) SARS-CoV (2002-3) which emerged out of China and caused the outbreak of Severe Acute Respiratory Syndrome (SARS) was more deadly but much less infectious than COVID-19. The virus rapidly spread across 29 countries but was eventually contained and there have been no outbreaks of SARS anywhere in the world since 2003. (2) MERS-CoV (2012) which emerged out of Saudi Arabia and had a death rate of 34% but which has been mainly limited to the Middle East. There are currently no vaccines or specific drug treatments for coronaviruses. Conditions that facilitate the creation of new strains Coronaviruses are zoonotic, meaning that they can be transmitted from people to animals. Both SARS-CoV, MERS-CoV and likely SARS-CoV-2 originally came from bats, though other animals that act as intermediaries spreading coronaviruses to humans. Many of the early cases of COVID-19 were traced back to the Baishazhou wet market in Wuhan (which has now re-opened despite pressure from the US in particular). Influenza Pandemics Flu Pandemics are not new – see attached chart. The deadliest was the “Spanish flu” which had both a high infection rate and death rate. Whilst this did not occur within the lifetime of most world leaders, there are still plenty of people alive today who would have been young children when that hit. World reaction The combination of high infection rate, a significant death rate and long incubation period have forced world governments into unprecedented action – lockdowns/stay-at-home orders have impacted most of the world’s population. As to what else is truly unprecedented, make your own mind up…

  • COVID-19: The second week cliff

    There is some very interesting data coming out of Wuhan, China about COVID-19, including more details of what happens to hospitalised patients with severe COVID-19. From anecdotal feedback we have got from EU doctors, this seems to be a close reflection of what is happening in Europe too. It does illustrate just how critical week 2 is to someone infected with the Coronavirus.

  • nuaxia upgrades and opens access to its specialist video analysis capability

    nuaxia, a healthcare information technology platform announces that it has significantly upgraded its proprietary technology platform. In December 2018, nuaxia announced the launch of its third generation platform which leverages 7 AI engines to deliver its unique, behavioural science based analytics. nuaxia has now completed a number of significant enhancements to improve the speed and scale by which its video data can be captured and analysed including: Visualisation tool for summarising and analysing video data Fast clip compilation tool Self-serve admin function for clients Enhanced blurring function A slick new user interface Re-engineered platform to a containerized system “Chatbot 1.0” capability for multi-part video questioning nuaxia is now offering this capability as a service that can be included within any market research survey.  This allows clients to access the benefits of the nuaxia platform whilst continuing to use their existing research and data collection providers. Peter Chopra, nuaxia’s CEO comments: “The market research industry has been struggling to properly leverage the value of video-based responses.  The key issue driving that is the huge amount of data that video provides. This problem is especially true for nuaxia’s clients as our approach goes beyond the words to measure emotional (system 1) responses too.  Leveraging our full service experience, we have created impactful and actionable client deliverables. Furthermore, we have significantly reduced the amount of analyst time required so that findings can be delivered at the speed of business. We will continue to focus on innovative and forward-thinking leaders and projects where delivering holistic and reliable research is paramount.” For further information, please visit nuaxia.com

  • nuaxia launches the third generation of its Technology Platform

    nuaxia, a healthcare information technology platform announces that it has launched the third generation of its proprietary technology platform​. nuaxia has made significant enhancements in five key areas: First, the development of an enterprise level system for storing and managing video data. Second, AI-powered analysis functionality to allow businesses to make fast, deep insight on visual information. Third, an extended suite of behavioural economics capabilities including tone of voice and word sentiment analysis to add to its facial coding capability which was launched at the start of this year. Fourth, a suite of reporting and collaboration tools to support the sharing and engagement in its video stories. Fifth, the development of API functionality to allow for easy integration of information into and out of its technology platform. nuaxia is now able to: ● Recruit respondents through its own HCP Membership and patients partnerships; ● Conduct both quantitative and qualitative video based research (both directly or using third party interview data); ● Create customer story libraries; and ● Provide automated analysis and reporting on video and traditional research data Peter Chopra, nuaxia’s CEO comments: “When we launched nuaxia, it was obvious that video based research would play a major role in how market research is conducted in the future. We, like the consumer video research specialists, have developed a full suite of video capture capabilities. However, no one seems to have properly realised the potential of this form of research yet. Our approach has been to focus on the analysis and reporting of visual data and our third generation platform has been developed to create an industry leading approach in this area. As the only healthcare focused video research specialist, our third generation platform not only enhances our capabilities on our existing services, it will also form the heart of a number of new specific service offerings in 2019.” For further information, please visit ​nuaxia.com

  • nuaxia incorporates Affectiva’s Emotion AI into its Platform

    LONDON, UK: February 13, 2018 – nuaxia, a healthcare information technology platform announces that it has entered into a strategic partnership with Affectiva, the global leader in Artificial Emotional Intelligence (Emotion AI). nuaxia will combine Affectiva’s facial coding with its video capture and analysis capability to provide clients with much deeper insights into their customers’ implicit meaning and system 1 thinking. In addition to the ability to process its videos using the Affectiva processing engine, nuaxia also announces some significant new functionality upgrades to its own platform. nuaxia’s video capture capacity now allows for video engagements to simultaneously show stimuli and capture responses in real time. nuaxia is also releasing a new video dashboard that allows clients full analysis capability. Peter Chopra, nuaxia’s CEO comments: “The emotional analytics market is forecast to exceed $1.7 billion by 2022. nuaxia has long advocated the benefits of augmenting traditional survey based research approaches with deeper “system 1” driven analytics. Our relationship with Affectiva will open this capability to the healthcare sector.” Dr. Rana el Kaliouby, Affectiva co-Founder and CEO, commented: "We're very excited to be working with nuaxia, a pioneering company in the healthcare sector. Emotions predict customer behavior, brand perception and brand loyalty. Our emotion recognition technology is perfectly suited to nuaxia’s unique strengths in capturing video and voice responses. Both organizations are focused on gaining a far deeper insight into the reasons behind decision-making and this partnership is set to benefit the world’s largest healthcare brands and their customers About www.nuaxia.com: nuaxia is a healthcare focused marketing, information, research and recruitment business. It currently offers businesses and institutions in the healthcare sector the ability to launch Video Interviews and Micro Engagements with healthcare experts and patients using its technology Platform. nuaxia processes work "at the speed of business" to provide better quality engagements that better impact and influence decision-making. nuaxia positions itself as putting its Members First (physicians, other healthcare professionals and patients). By putting its Members First, nuaxia is tackling the industry issue of plummeting response rates in order to provide its Clients with results that can be relied upon for decision-making. About Affectiva: Affectiva is the pioneer in Emotion AI, the next frontier of artificial intelligence. Affectiva's mission is to bring emotional intelligence to the digital world with its emotion recognition technology that senses and analyzes facial and vocal expressions of emotion. Affectiva's patented software is built on an emotion AI science platform that uses computer vision, deep learning and the world's largest emotion data repository of nearly 6 million faces analyzed from 87 countries, amounting to more than 2 billion facial frames. For more information on Affectiva, please visit www.affectiva.com.

  • nuaxia completes Series A funding and launches “version 2” of its Platform

    LONDON, UK: November 28, 2017 – nuaxia, a healthcare information technology platform announces that it has completed its Series A fund raising which has successfully raised £0.5 million. nuaxia announces that it has successfully completed its latest round of fund raising. The funds will be used to accelerate product development leveraging its technology centre in Budapest, Hungary. nuaxia also announces today the launch of its “version 2” Platform. This Platform is a significant improvement on the original platform providing improved functionality, greater flexibility in service capabilities, easier integration with other systems and fast processing of large data sets. nuaxia is also extending its video services with the launch its Video Discussion Group capability which allows its clients to conduct online video focus group meetings. Peter Chopra, Founder and CEO, commented: “The launch of the “version 2” platform is a landmark for nuaxia. It will allow us to launch a series of new products, starting with the Video Discussion Group service announced today, and continuing into 2018. The success of our Series A funding will provide the investment funds to support those developments. We continue to see our video and micro-engagement services as representing the future direction for healthcare research.”

  • nuaxia Closes £1M Seed Funding Round

    Friday, 23 December 2016 nuaxia is an information technology business serving the healthcare sector. nuaxia has successfully closed its seed funding round, raising an impressive £1 million for the new business. The funds will be used to finance nuaxia’s technology platform, develop its proprietary databases, and provide working capital for its launch and initial trading activities. “I am very excited that we have successfully completed our fundraising exercise” said Founder and CEO, Peter Chopra. “We have been working on the development of this new business for more than a year and it is fantastic to be so close to our official launch.” For further information, please visit nuaxia.com For media inquiries: Peter Chopra, peter@nuaxia.com

  • New Healthcare Information Technology Platform ‘nuaxia’ Launches Its ‘Fresh Value’ Service

    Friday, 20 January 2017 nuaxia, a multimedia short survey platform for healthcare professionals, officially goes live today. nuaxia offers businesses and institutions in the healthcare sector the ability to launch short surveys to healthcare professionals through its easy-to-use, self-serve, automated platform. With questions launched in minutes and results dashboarded in as little as a few hours, nuaxia brings customer insights into decision-making in real-time and at a cost that all businesses can afford. nuaxia is the first company to provide Do-It-Yourself (“DIY”) video, picture and voice responses. The company focuses primarily on empowering its users through quicker and better quality responses to impact and influence decision-making. In another first, nuaxia positions itself as putting its Members (physicians and other healthcare professional respondents) before its Clients. nuaxia is tackling the “inconvenient” industry issue of plummeting response rates head on in order to provide its Clients with results that can be relied upon for decision-making. The service, designed around mobile devices and promising to fit into the lives of its Members already boasts over one million Members. “I am delighted to be able to announce the development of our Platform, databases and the launch of our first service in such a short timeframe,” said Founder and CEO, Peter Chopra. “We are major advocates for using technology to empower our Clients and Members and for a business model that respects the way that our behaviors have evolved. Now that we have a demonstration of that ethos with our new product launch, we are looking forward to collaborating with both our Clients and our Members to evolve the Platform into new and exciting areas.”

bottom of page